FGFR1 and breast carcinoma: The genomic analysis of The Cancer Genome Atlas (TCGA) and the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) databases has confirmed that the amplification of FGFR1 is the highest among the FGFR family members, as it occurs in nearly 14% of breast cancer patients [9].